Currently, the most popular means of assessing functional activity of Gs/olf-coupled receptors is via the measurement of intracellular cyclic adenosine monophosphate (cAMP) accumulation. An additional readout is the downstream phosphorylation of cAMP response element binding protein (CREB), which gives an indication of gene transcription, the ultimate response of many G-protein-coupled receptor (GPCR) signals. Current methods of quantifying CREB phosphorylation are low throughput, and so we have designed a novel higher throughput method using the Odyssey™ infrared imaging system. Functional potencies of both agonists and antagonists correlate well with radioligand binding affinities determined using examples of both an endogenous (adenosine 2A receptor in PC-12 cells) and a heterologous (human melanocortin 4 receptor in HEK-293 cells) expression system. For example, the antagonist ZM241385 demonstrates 0.23 ± 0.03 nM affinity for the A 2A receptor and has a functional potency of 0.26 ± 0.04 nM determined using cAMP and 0.15 ± 0.06 nM using CREB phosphorylation. These data demonstrate that this novel approach for the measurement of CREB phosphorylation is a useful tool for the assessment of GPCR activity in whole cells and is more amenable to the throughput required for the purposes of drug discovery. (Journal of Biomolecular Screening 2006:351-358) 
H IGH-THROUGHPUT WHOLE CELL ASSAYS for the measurement of G-protein-coupled receptor (GPCR) functional activity for drug discovery are mainly focused at upstream signaling events such as the accumulation of 2nd messengers like cyclic AMP (cAMP) and inositol phosphates. Although useful, such readouts may not portray accurate information regarding downstream events, which are closer to the ultimate response that will be elicited by a compound. Such an event might be the initiation of gene transcription. cAMP response element binding protein (CREB) is a nuclear-located transcription factor that remains inactive until it is phosphorylated by the catalytic unit of protein kinase A (PKA-C). Accumulation of cAMP in response to Gs/olf-linked GPCR activation results in disassociation of the regulatory subunits of PKA from the catalytic subunits and the translocation of PKA-C from the cytosol into the nucleus where it phosphorylates CREB on residue Ser 133. 1 Once phosphorylated, phospho-CREB (P-CREB) forms a dimer, which binds to the conserved palindromic response element, TGACGTCA, known as the cAMP-regulated enhancer (CRE), located in the promoter region of cAMP-inducible genes. 2 Phospho-CREB, bound to the CRE site, recruits the coactivator of gene transcription, CREB-binding protein, which initiates gene transcription through association with DNA polymerase II and intrinsic histone acetyltransferase activity. 3, 4 There are many genes that contain the CRE site and indeed the half-motif CGTCA, and these genes are involved in diverse processes such as metabolism, gene transcription, neuronal functioning, and the cell cycle. 5 Thus, CREB is considered an important protein in the control of many physiologic processes, and its regulation may be a good indicator of a compound's capability to alter cellular responses for the purposes of drug therapy.
Direct assessment of CREB activation involves the measurement of a phosphorylation event, which is usually performed by Western blot employing phospho-specific antibodies [6] [7] [8] but can also be achieved by the incorporation of a radiolabeled phosphate group and the use of autoradiography. Western blot techniques are relatively lengthy and have a very low throughput, depending on the number of available wells on a gel (typically 10) and the number of gels that can be handled at one time. In additional, quantification is complicated by the fact that the signal is often nonlinear, with strong signals often saturating the capture film. 9 cAMP response element binding protein activity can also be measured by quantification of target gene expression using reporter genes such as luciferase. 7 However, this methodology requires the introduction of the exogenous reporter construct into the cell via transfection and may interfere with the stoichiometry of an endogenous response depending on the transfection efficiency. 10 Here we describe a technique whereby CREB activation can be directly assessed using specific antibodies in whole cells without the need for additional sample preparation and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). The technique is described as an in-cell Western using near infraredlabeled secondary antibodies and an infrared scanning device known as the Odyssey™ (LI-COR ® Biosciences, Lincoln, NE). This machine has the ability to scan at 2 separate wavelengths (700 and 800 nm) and thus simultaneously quantify the levels of 2 distinct proteins utilizing antibodies conjugated to differentially excitable fluorophores. Using the Odyssey™, methods have been successfully developed to assess extracellular regulated kinase phosphorylation 11 and GPCR internalization. 12 Assays are directly quantitative and can be performed in 96-or 384-well format. Using the Odyssey™ here, we demonstrate that the functional potency of adenosine 2A (A 2A ) receptor antagonists assessed using CREB phosphorylation closely resembles that of their binding affinity and the functional antagonism achieved using the more upstream readout of cAMP accumulation in PC-12 cells. Moreover, we demonstrate that this technique works equally well in a native versus recombinant overexpression system.
MATERIALS AND METHODS

Materials
CGS-21680, CGS-15943, ZM241385, and rolipram were purchased from Tocris Bioscience (Ellisville, MO). SCH58261, adenosine, and adenosine deaminase type IV from calf spleen were purchased from Sigma-Aldrich Company (St. Louis, MO). α-MSH was obtained from Peninsula Laboratories (Belmont, CA), and the nonpeptide agonists THIQ 13 and NBI-58702 14 were synthesized by the Chemistry Department at Neurocrine Biosciences, Incorporated (San Diego, CA). Primary antibodies against total CREB and P-CREB were obtained from Upstate (Charlottesville, VA), the 800-nm infrared-labeled goat antirabbit secondary antibody was obtained from Rockland Immunochemicals (Gilbertsville, PA), and the 680-nm infrared-labeled goat antimouse secondary antibody was obtained from Molecular Probes (Invitrogen Corporation, Carlsbad, CA). Odyssey™ blocking buffer was purchased directly from LI-COR ® Biosciences (Lincoln, NE). All other materials, unless otherwise stated, were of analytical grade and purchased from Sigma-Aldrich Company.
Cell culture
PC-12 cells were grown on Biocoat collagen I cellware 175 cm 2 flasks (Becton Dickenson Labware, Bedford, MA) in Opti-MEM medium with GlutaMAX (Invitrogen, Carlsbad, CA) supplemented with 50 U/mL penicillin, 50 µg/mL streptomycin, 10% heat-inactivated horse serum, and 5% heat-inactivated fetal bovine serum. Human embryonic kidney (HEK) cells expressing the human melanocortin 4 receptor (HEK-MC4R) were grown in minimal essential medium (MEM) supplemented with 50 U/mL penicillin, 50 µg/mL streptomycin, 10% heat-inactivated fetal bovine serum, and 250 µg/mL G418. The cells were grown in a 5% carbon dioxide humidified incubator and passaged every 4 to 5 days.
Western blotting
Samples for Western blotting were prepared from PC-12 cells plated on 6 well plates, which had been precoated with 0.1 mg/mL collagen type I from rat tail (BD Biosciences, Bedford, MA) plus 0.1 mg/mL poly-D-lysine. Sixteen hours before sample preparation, the cells were serum-starved by the replacement of the cell culture medium with identical medium lacking horse and fetal bovine serum. Drugs were added directly to the cell culture medium and allowed to remain in contact with the cells for 20 min before aspiration and the addition of 2× Laemmli's buffer (125 mM tris hydrochloride [HCl], 4% SDS, 20% glycerol, 50 mM dithiothreitol, 0.001% bromophenyl blue, pH 6.8) for 10 min. The samples were then made 1:1 with water and boiled at 95°C for 5 min, before 20 µL was loaded onto 10% BisTris gels and electrophoresed at 140 V for 120 min using SDS MES buffer (both from Invitrogen, Carlsbad, CA). Transfer to nitrocellulose membrane was achieved at 16 V for 26 min using a semidry apparatus. After blocking for 1 h at room temperature with Odyssey™ blocking buffer, membranes were then probed simultaneously with primary antibodies, rabbit antitotal CREB (1:2000) and mouse anti-P-CREB (1:6000), for 1 h, and then goat antirabbit 800 and goat antimouse 680 secondary antibodies (both at 1:20,000) for 45 min. After the final washes, the membranes were scanned using the Odyssey™ Infrared Imager (84 µm resolution, 0 mm offset with high quality).
In-cell Westerns
Twenty-four hours before assay, the cells were plated onto Nunclon™ ∆ surface 96-well plates (Nunc A/S, Roskilde, Denmark) precoated with either 0.1 mg/mL collagen type I plus 0.1 mg/mL poly-D-lysine for PC-12 cells, or 0.1 mg/mL poly-D-lysine alone for HEK-MC4R cells. PC-12 cells were plated at a density of 125,000 cells/well, and HEK-MC4R cells were plated at 70,000 cells/well. Immediately after plating, the cells were allowed to settle and adhere to the plate at room temperature for 15 min before being returned to the humidified incubator to prevent edge effects. 15 Sixteen hours before assay, the cells were serum starved by the replacement of culture medium with 100 µL/well serum-free medium.
Drug additions were made directly to the culture wells. Agonists were added for a 20-min stimulation (unless otherwise stated). Antagonists, when used, were added 10 min before the agonist. Experiments were performed at 37°C and terminated by aspiration of the drug-containing medium and by the addition of 100 µL 4% paraformaldehyde for 20 min at room temperature. After removal of the paraformaldehyde, the cells were permeabilized by washing 5 times for 5 min each with 200 µL/well of 0.1% TritonX-100 in phosphate-buffered saline (PBS) before the addition of 100 µL/well Odyssey™ blocking buffer for 2 h with gentle shaking. The cells were next incubated with 50 µL/well primary antibody, either mouse anti-P-CREB alone (1:2400) or in combination with rabbit antitotal CREB (1:800), overnight at room temperature. After 5 washes with 200 µL/well 0.1% Tween-20 in PBS, the cells were incubated with 50 µL/well secondary antibody, either goat antimouse 680 alone (1:400) or in combination with goat antirabbit 800 (1:800), for 1 h at room temperature. Finally, the cells were once again washed 5 times with 200 µL/well 0.1% Tween-20 in PBS before being scanned using the Odyssey™ Infrared Imager (169 µm resolution, 3.2 mm offset with medium quality).
Membrane preparation
Crude membranes were prepared from PC-12 cells endogenously expressing the A 2A receptor by washing with PBS and resuspending the cells in lysis buffer (50 mM tris-HCl, 5 mM EDTA, 10 mM magnesium chloride [MgCl 2 ], pH 7.4). The cells were disrupted for 30 min on ice under N 2 at a pressure of 900 lb/in 2 pounds per square inch using a Parr Cell disruption bomb, followed by differential centrifugation. The resulting crude membrane pellet was resuspended in assay buffer (50 mM tris-HCl, 1 mM EDTA, 10 mM MgCl 2 , pH 7.4). Membrane protein concentration was determined by Bradford assay, and aliquots were stored at -80°C.
Radioligand binding
Membranes (15-20 µg of protein), resuspended in assay buffer, were preincubated for 30 min at room temperature in the presence of 10 µg/mL adenosine deaminase to degrade endogenous adenosine. Membranes were then incubated for 90 min with 1 nM [ 3 H]-ZM241385 (Specific Activity 27.40 Ci/mmol, Tocris Bioscience, Ellisville, MO) in the presence of varying concentrations of competing ligand in a total volume of 200 µL.
Nonspecific binding was determined in the presence of excess CGS-15943 (1 µM). Bound and free ligands were separated by rapid vacuum filtration using a Packard 96-well cell harvester onto UniFilter GF/C filter plates (PerkinElmer, Boston, MA) that had been pretreated with 0.5% polyethylenimine. Filter plates were than washed with 3 × 200 µL 50 mM tris HCl, 50 mM sodium chloride, pH 7.4. Bound radioligand was determined by scintillation counting using a TopCount-NXT.
cAMP accumulation
One day before assay, PC-12 cells were seeded in 96-well culture plates coated with 0.1 mg/mL poly-D-lysine and collagen at 3.5 × 10 4 cell/well in Opti-MEM media supplemented with 10% dialyzed fetal bovine serum. The day of the assay, the cells were washed with 200 µL PBS and incubated with 50 µL assay media (Dulbecco's modified eagle's medium without phenol red, 1 mM N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid, 2 mM L-Glutamine, 30 µM rolipram) in the presence of 10 µg/mL adenosine deaminase for 30 min at 37°C. Cyclic AMP formation was stimulated for 20 min at 37°C in a total volume of 100 µL by the A 2A selective agonist CGS-21680 (55 nM final) in the presence or absence of varying concentrations of antagonist. After the incubation, the cells were aspirated dry, and 30 µL PBS was added immediately. The cells were then lysed for 1 h at room temperature with shaking by addition of 20 µL antibody/lysis buffer. Cyclic AMP accumulation was quantitated by competitive immunoassay (cAMP XS HitHunter Assay kit, Amersham Biosciences, Piscataway, NJ) and relative light units measured for 300 s on ViewLux microplate imager (PerkinElmer, Boston, MA).
Data analysis
In-cell Western data were analyzed using the Odyssey™ in-cell plug-in software. Included in all 96-well plates were no primary antibody control wells. The fluorescence from these wells was taken as background fluorescence and subtracted from all sample wells. Where the rabbit antitotal CREB antibody was used in conjunction with the goat antirabbit 800 secondary antibody, P-CREB fluorescence at 680 nm within each well was normalized to that of the total CREB fluorescence at 800 nm within the same well.
Concentration-response curves were analyzed using a commercially available program (Prism 4.0, GraphPad Software, San Diego, CA) to generate EC 50 and concentration that inhibits binding or activity by 50% (IC 50 ) values. IC 50 values were converted to inhibition rate constant (K i ) and apparent dissociation equilibrium constant for a competitive antagonist (K B ) values using the Cheng-Prusoff equation 16 ; for K B values, the hill slope was assumed to be equal to 1. 17 Schild analysis was performed by linear regression using GraphPad Prism to generate pA 2 values. 18, 19 Measuring High-Throughput CREB Phosphorylation Statistical significance between EC 50 and maximal response (E max ) values determined for CGS-21680 dose-response curves using the P-CREB antibody alone or in conjunction with either total-CREB antibody was assessed using repeated measures analysis of variance (ANOVA) for paired observations with post hoc Tukey. For binding the negative log of K i (pK i ) and cAMP/P-CREB apparent negative log of K B (pK B ) values for the different antagonists, analysis was made using 1-way ANOVA with post hoc Tukey.
RESULTS AND DISCUSSION
Western blotting
Before running in-cell Westerns with a given antibody, it should first be established by conventional Western blot whether the antibody recognizes a single specific band at the correct molecular weight. This is especially important for the antibody derived against the phospho-specific form of the protein of interest, which will be used to determine the amplitude of the response. As such, Figure 1 details the Western blot profile for 2 distinct antibodies derived against amino acids 5 through 24 of human CREB, 1 rabbit polyclonal, 1 rabbit monoclonal, and for a mouse monoclonal antibody derived against amino acids 125 through 135 of human P-CREB. Both antibodies against total CREB bind to multiple proteins of varying molecular weight in lysates prepared from PC-12 cells. The rabbit polyclonal recognizes total CREB at approximately 43 kDa with the highest intensity, yet it also detects multiple additional nonspecific bands ranging from approximately to 38-52 kDa (Fig. 1B, total CREB) . The rabbit monoclonal again recognizes total CREB at approximately 43 kDa but also detects a nonspecific band at approximately 60 kDa with greater intensity than the specific band ( Fig. 1A, total CREB ). In addition, this antibody detects faint nonspecific bands in the region of approximately to 48-65 kDa. The mouse monoclonal antibody against P-CREB displays a cleaner profile, detecting a specific high intensity single band at approximately 43 kDa and a much lower intensity band at approximately 36 kDa ( Fig. 1, P-CREB) , which is thought to be attributed to the cAMP response element modulator and/or activation transcription factor 1 proteins that belong to the same family of genes as CREB and that share similar sequence homology with the P-CREB immunizing peptide. 20, 21 The P-CREB band is clearly enhanced in samples that have been stimulated with either Forskolin (10 µM) or the A 2A receptor agonist, CGS-21680 (100 nM), 22 and is only very weak in the basal sample prepared from untreated cells. It is also noteworthy that in the overlay image, the P-CREB runs at a slightly higher molecular weight than the total CREB, with the red band running at the top of the overlay yellow band, which is presumably attributed to the addition of the phosphate group.
In-cell Westerns
To determine whether the use of different combinations of antibodies alters the EC 50 of the agonist response, or indeed the size of the response, in-cell Westerns were performed to generate simple CGS-21680 dose-response curves in PC-12 cells. The mouse anti-P-CREB antibody was either used alone or in combination with the rabbit polyclonal or rabbit monoclonal anti-CREB antibodies for normalization purposes (Figs. 2 A  and B) . EC 50 values did not significantly alter, depending on whether the P-CREB antibody was used alone or in conjunction with either of the total CREB antibodies (EC 50 [nM] alone = 2.52 ± 0.29, + polyclonal total CREB = 2.98 ± 0.36, + monoclonal total CREB = 2.74 ± 0.23, p > 0.05). The relative maximal response elicited by the agonist did vary, however, depending on the combination of antibody used. Statistically significant differences in E max for CGS-21680 were not evident when comparing the P-CREB antibody alone or in combination with either of the total CREB antibodies (E max [% basal] alone = 613 ± 52, + polyclonal total CREB = 770 ± 93, + monoclonal total CREB = 481 ± 76, p > 0.05), yet the E max obtained using the combination of the rabbit polyclonal total CREB plus the P-CREB antibody was significantly greater than that obtained using the combination of rabbit monoclonal total CREB plus the P-CREB antibody (p < 0.05). This difference may be attributed to the fact that the rabbit monoclonal total CREB antibody detects such a high intensity nonspecific band (at ~60 kDa) and therefore diminishes the specific signal. Agonist dose-response curves were also generated for adenosine, the endogenous agonist for the A 2A receptor, which elicited an E max comparable to that of CGS-21680 and an EC 50 of 0.97 ± 0.32 µM.
In addition to the endogenous A 2A R-mediated response in PC-12 cells, agonist dose-response curves were generated in HEK-MC4R cells using the agonists α-MSH, THIQ, and NBI-58702 to demonstrate that P-CREB in-cell Westerns can also be successfully performed in an overexpression system, provided the basal CREB phosphorylation is not so high as to occlude the agonist driven response (Fig. 2C) .
Having determined that the agonist EC 50 for CGS-21680 was not significantly different when determined using the P-CREB antibody alone to that using the CREB/P-CREB combinations, we opted to use the single antibody in future experiments. A time course of CREB phosphorylation performed in PC-12 cells in response to both CGS-21680 and to the endogenous agonist adenosine revealed that CREB phosphorylation occurred in a linear fashion up to 5 min, which subsequently plateaued at 20 min and remained stable for a further 40 min ( Fig. 3) . At this point, no more additional phosphorylation was observed, yet loss of phosphorylated CREB was also not evident. Thus, either the rate of phosphorylation and dephosphorylation were equal or there is a greater than 60 min lag on the removal of the phosphate group from CREB in this system. Gene transcription in response to cAMP stimulation usually peaks at 30 min, the time it takes for the catalytic subunit of protein kinase C to reach maximal levels in the nucleus. 23 Under continuous stimulation, transcriptional activity begins to decline after this point and returns to basal after approximately 2 to 4 h, depending on the activity of phosphatases PP-1 and PP-2A that are responsible for the dephosphorylation of CREB. 24, 25 Our peak in CREB phosphorylation at the 20-min time point is therefore reflective of that which has been documented in the literature and was thus chosen as optimal for further experiments to determine antagonist potencies.
In-cell Western data versus cAMP and radioligand binding
Functional potencies of antagonists in the P-CREB in-cell Western were assessed by stimulating CREB phosphorylation in PC-12 cells with an approximate EC 80 concentration of CGS-21680 (4 nM) and then inhibiting this response with increasing concentrations of the known A 2A receptor antagonists ZM241385, 26 SCH58261, 27 KW6002, 28 and CGS-15943 29 to generate IC 50 values (Fig. 4) . Also performed within each 96-well plate was a CGS-21680 dose-response curve to generate the EC 50 of the agonist for that given day so that the antagonist IC 50 values could be converted to apparent K B (ap K B ) values using the Cheng-Prusoff equation. These ap K B values were compared to the K i values generated from radioligand binding assays performed on PC-12 cell membranes and also to ap K B values determined by performing cAMP enzyme-linked immunosorbent assay on intact PC-12 cells ( Table 1) . Apparent K B values obtained in the cAMP and P-CREB assays were statistically comparable for all 4 antagonists tested, and these also closely matched the binding affinities. Thus, in this native expression system for the A 2A receptor, there was no discrepancy between binding affinity and functional potency (correlation r 2 = 0.94) that has been documented in an A 2A receptor expressed in Chinese hamster ovary cells (CHO-A 2A ) overexpressing cell line where the potency of ZM241385 was determined by Schild plot to be 6.6 nM, yet the binding affinity was 0.2 nM. 30 Using the CREB assay described here, Schild analysis of consecutive shifts of CGS-21680 dose-response curves with increasing concentrations of the antagonist ZM241385 generated a pA 2 value (the negative log of the molar concentration of an antagonist that makes it necessary to double the agonist concentration required to elicit the original submaximal response obtained in the absence of antagonist) 18,19 of 9.66 ± 0.24 (n = 3), which also did not differ significantly from the binding affinity or ap K B values generated by inhibition of agonist-stimulated responses in cAMP or P-CREB ( Fig. 5) . Thus, our novel means of assessing CREB phosphorylation generated data that consistently mirrored those produced using the standard, widely accepted technique of assessing cAMP accumulation and also the binding.
CONCLUSION
This article describes a higher throughput means of assessing CREB phosphorylation in response to GPCR activation in intact cells via in-cell Western blotting using the Odyssey™ infrared imager. This assay is performed in 96-well format and thus allows the user to perform up to eight 12-point doseresponse curves per plate (single points), which, for comparison, would require the use of ten 10-well conventional Western blotting gels to be electrophoresed simultaneously, with the potential for error because not all concentrations within a doseresponse curve would be able to be performed on the same gel. The Z value determined for this 96-well P-CREB assay was determined as 0.51 with a signal:background of 4.3, which according to the criteria set out by Zhang and others 31 demonstrates it is an excellent assay. Reproducibility and throughput are therefore comparable to any assay performed in 96-well format such as cAMP accumulation or fluorometric imaging plate reader; moreover this assay has the potential to be expanded to 384-well format. We have demonstrated that data generated using this technique are not significantly altered whether the user takes advantage of phospho-specific pairs of antibodies or simply uses the single antibody directed against the phosphoprotein alone. Such a determination not only allows for reduction in the cost of running the assay but also opens up the technique to assessment of phosphorylation events that do not have the luxury of phospho-specific antibody pairs. The time course of CREB phosphorylation determined using this technique is in keeping with that published in the literature with the peak occurring at the 20-min time point and remaining constant for up to 60 min. Moreover, data generated using this technique are virtually identical to those generated with the more upstream signaling event of cAMP accumulation and, in addition, are very much in line with the affinity of the compound as assessed by radioligand binding. Because the ultimate response of GPCR activation may be an alteration in gene expression, a functional readout of an event just upstream of gene transcription that mirrors the binding affinity of a small molecule may provide a considerable advantage in lead compound selection. This technique works equally well in native and exogenous receptor overexpression systems, is not labor intensive, is relatively cost-effective, and has the potential to be translated into 384-well capacity to further increase throughput.
